Welcome to our Carlsbad clinic, where hope meets innovation with Spravato—a groundbreaking treatment for those battling treatment-resistant depression. Under the expert care of Jennifer Kalia Overlie, NP, we are proud to offer this revolutionary therapy that promises rapid relief and a renewed sense of well-being. Step into a supportive environment where cutting-edge science and compassionate care converge to help you reclaim your life. Discover the transformative potential of Spravato and embark on your journey to a brighter, more fulfilling future.
Getting Started on SPRAVATO
-
Spravato, also known as esketamine, is a FDA-approved nasal spray treatment for individuals with treatment-resistant depression or increased suicidality. This is designed for individuals who have tried other antidepressant medications yet have not received adequate benefit from them. Spravato works differently than traditional antidepressants and has been shown to improve and/or alleviate the symptoms of depression faster and more effectively.
-
Spravato is intended for adults with major depressive disorder who have not responded adequately to at least two different antidepressant treatments. It is used in conjunction with an oral antidepressant to enhance its effectiveness.
-
Administered as a nasal spray, Spravato is taken under the supervision of a healthcare professional in our office. After administration, patients are monitored for approximately two hours to ensure safety and manage any side effects.
We understand that each person’s journey with mental health is unique, and we are committed to providing personalized care that caters to your specific needs. If you believe you or a loved one could benefit from Spravato treatment, or if you have any questions about this new service, please do not hesitate to contact us.
Ketamine Treatment
Ketamine treatment uses ketamine, originally an anesthetic, for its rapid antidepressant effects in treatment-resistant depression and mood disorders. Administered as a nasal spray like Spravato (esketamine), it targets the brain's glutamate system to promote neural connections, leading to quick mood improvements.
Savings Program
Eligible patients pay as little as $10 per treatment. There are quantity limits and a maximum program benefit per calendar year. Offer subject to change or end without notice. Program does not cover the cost of treatment observation. Participate without sharing your income information
Schedule a consultation to explore whether Spravato is a suitable treatment option for you. Discuss this with your provider at your next appointment.